KCNIP3 and glioblastoma: Editor's choice: Putative DREAM-binding sites were identified for 151 genes associated with blood or brain abnormalities and mutation of 21 sites impacted gene expression, suggesting that p53-DREAM alterations contribute to bone marrow failure and glioblastoma cell phenotypes.